A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
© 2018 The Author(s) Background: Reducing the dose of efavirenz can improve safety, reduce costs, and increase access for patients with HIV infection. According to the World Health Organization, a similar dosing strategy for all patient populations is desirable for universal roll-out; however, it re...
Saved in:
Main Authors: | Stein Schalkwijk, Rob Ter Heine, Angela C. Colbers, Alwin D.R. Huitema, Paolo Denti, Kelly E. Dooley, Edmund Capparelli, Brookie M. Best, Tim R. Cressey, Rick Greupink, Frans G.M. Russel, Mark Mirochnick, David M. Burger |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043397210&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/58961 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
by: Stein Schalkwijk, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019) -
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
by: Stein Schalkwijk, et al.
Published: (2019) -
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
by: Tim R. Cressey, et al.
Published: (2018) -
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
by: Cressey T., et al.
Published: (2017)